MorphoSys AG (XTER:MOR)
€ 67.25 0 (0%) Market Cap: 2.53 Bil Enterprise Value: 2.49 Bil PE Ratio: 0 PB Ratio: 51.57 GF Score: 45/100

Q3 2021 MorphoSys AG Earnings Call Transcript

Nov 11, 2021 / 01:00PM GMT
Release Date Price: €37.39 (-2.63%)
Operator

Ladies and gentlemen, welcome to the MorphoSys Third Quarter 2021 Financial Results Conference Call. (Operator Instructions). I would like to turn the conference over to Julia Neugebauer. Please go ahead.

Julia Neugebauer
MorphoSys AG - Former Director of Corporate Communications & IR

Ladies and gentlemen, good afternoon or good morning. My name is Julia Neugebauer, Senior Director, Investor Relations of MorphoSys and it is my pleasure to welcome you to our Third Quarter 2021 Financial Results Conference Call.

Joining me on the call today are Jean-Paul Kress, Chief Executive Officer; Sung Lee, Chief Financial Officer and Malte Peters, Chief Research and Development Officer. Joe Horvat, U.S. General Manager, will be available for the Q&A session. Before we begin, I'd like to remind you on Slide 2 that some of the statements made during the call today are forward-looking statements, including statements regarding our expectations for the commercialization of our products and our development plans, impact of COVID-19 on our business and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot